Quality of life after a diagnosis of prostate cancer among men of lower socioeconomic status: Results from the Veterans Affairs Cancer of the Prostate Outcomes Study

Urology

Volumn 61, Issue 1, 2003, Pages 172-178

  Siston, Amy K ^a,b,c,d   Knight, Sara J ^a,b,c,d   Slimack, Nicholas P ^a,b,c,d   Chmiel, Joan S ^a,b,c,d   Nadler, Robert B ^a,b,c,d   Lyons, Thomas M ^a,b,c,d   Kuzel, Timothy M ^a,b,c,d   Moran, Edgar M ^a,b,c,d   Sharifi, Roohollah ^a,b,c,d   Bennett, Charles L ^a,b,c,d  

^a Veterans Aff Chicago H C S W D   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d VA LONG BEACH HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CONTROLLED STUDY; HEALTH STATUS; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE SURGERY; QUALITY OF LIFE; QUESTIONNAIRE; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SOCIAL STATUS; SOCIOECONOMICS; STATISTICAL ANALYSIS;

AGED; COMORBIDITY; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT EDUCATION; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; SOCIAL CLASS; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS; VETERANS;

EID: 0037259837     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(02)02141-6     Document Type: Article

References (25)

1. Schapira M.M., Lawrence W.F., Katz D.A., et al. Effect of treatment on quality of life among men with clinically localized prostate cancer. Med Care. 39:2001;243-253.
2. Crawford D.E., Eisenberger M.A., McLeod D.G., et al. A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. N Engl J Med. 321:1989;419-424.
3. Schmitt B., Wilt T.J., Schellhammer P.F., et al. Combined androgen blockade with nonsteroidal antiandrogens for advanced prostate cancer systematic review. J Urol. 57:2001;1-7.
4. Litwin M.S., Hays R.D., Fink A., et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA. 273:1995;129-135.
5. Borghede G., Sullivan M. Measurement of quality of life in localized prostatic cancer patients treated with radiotherapy development of a prostate cancer-specific module supplementing the EORTC QLQ-C30. Qual Life Res. 5:1996;212-221.
6. Jonler J., Nielsen O.S., Wolf H. Urinary symptoms, potency, and quality of life in patients with localized prostate cancer followed up with deferred treatment. Urology. 52:1998;1055-1063.
7. Cassileth B.R., Soloway M.S., Vogelzang N.J., et al. Quality of life and psychological status in stage D prostate cancer. Qual Life Res. 1:1992;323-329.
8. Catalona W.J. Management of cancer of the prostate. N Engl J Med. 331:1994;996-1004.
9. Peeling W.B. Phase III studies to compare goserelin with orchiectomy and with diethylstilbestrol in treatment of prostate carcinoma. J Urol. 33:1989;45-52.
10. Herr H.W., Kornblith A.B., Ofman U. A comparison of the quality of life of patients with metastatic prostate cancer who received or did not receive hormonal therapy. Cancer Suppl. 71:1993;1143-1150.
11. Moinpour C.M., Savage M.J., Troxel A., et al. Quality of life in advanced prostate cancer results of a randomized therapeutic trial. J Natl Cancer Inst. 90:1998;1537-1544.
12. Stanford J.L., Feng Z., Hamilton A.S., et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer. JAMA. 283:2000;354-360.
13. Yarbo C.H., Ferrans C.E. Quality of life of patients with prostate cancer treated with surgery or radiation therapy. Oncol Nurs Forum. 25:1998;685-693.
14. Lilleby W., Fossa S.D., Waehre H.R., et al. Long-term morbidity and QOL in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy. Int J Radiat Oncol Biol Phys. 43:1999;735-743.
15. Lubeck D.P., Litwin M.S., Henning J.M., et al. Changes in health-related quality of life in the first year after treatment for prostate cancer results from CaPSURE. J Urol. 53:1999;180-186.
16. Potosky A.L., Legler J., Albertsen P.C., et al. Health outcomes after prostatectomy or radiotherapy for prostate cancer results from the prostate cancer outcomes study. J Natl Cancer Inst. 92:2000;1582-1592.
17. Fonseca M.L., Smith M.E., Klein R.E., et al. The Department of Veterans Affairs medical care system and the people it serves. Med Care. 34:(suppl):1996;MS9-MS20.
18. Aaronson N.K., Ahmedzai S., Bergman B., et al. The European Organization for Research and Treatment of Cancer QLQ-C30 a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 85:1993;365-376.
19. Ringdal G.I., Ringdal K. Testing the EORTC quality of life questionnaire on cancer patients with heterogeneous diagnosis. Qual Life Res. 2:1993;109-112.
20. Hahn E.A., Cella D. Unbiased quality of life measurement across literacy levels and mode of administration. Qual Life Res. 6:1997;654.
21. Hahn E.A., Cella D. Unbiased quality of life measurement across literacy levels and administration modes in Spanish-speaking cancer/HIV patients. Qual Life Res. 9:2000;269.
22. Roach M. Neoadjuvant total androgen suppression and radiotherapy in the management of locally advanced prostate cancer. Semin Urol Oncol. 14:1996;32-37.
23. Albertsen P.C., Aaronson N.K., Muller M.J., et al. Health-related quality of life among patients with metastatic prostate cancer. J Urol. 49:1997;207-217.
24. Bennett C.L., Ferreira M.R., Davis T.C., et al. Relation between literacy, race, and stage of presentation among low-income patients with prostate cancer. J Clin Oncol. 16:1998;3101-3104.
25. Knight SJ, Chmiel JS, Kuzel TA, et al: Quality of life in metastatic prostate cancer among men of lower socioeconomic status: feasibility and criterion related validity of 3 measures. J Urol 160: 1765-1769, 1998.